Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan
Abstract
Resistance among uropathogenic Escherichia coli to trimethoprim-sulfamethoxazole (TMP-SMX) has increased. Risk factors for resistance and the impact on clinical failure have been poorly described. We performed a retrospective cohort study of women with acute uncomplicated cystitis seen at a universi …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
research support
non-u.s. gov't
adult
female
adolescent
aged
middle aged
risk factors
Retrospective Studies
Bacterial
drug resistance
Cohort Studies
escherichia coli / isolation & purification
drug combinations
anti-infective agents
urinary / pharmacology*
urinary tract infections / drug therapy
urinary tract infections / microbiology*
escherichia coli / drug effects*
prevalence
escherichia coli infections / microbiology*
michigan / epidemiology
sulfamethoxazole / therapeutic use
trimethoprim / therapeutic use
urinary tract infections / epidemiology
escherichia coli infections / epidemiology
pmid:11914994
doi:10.1086/339491
patricia d brown
alison freeman
betsy foxman
urinary / therapeutic use
escherichia coli infections / drug therapy
sulfamethoxazole / pharmacology*
trimethoprim / pharmacology*
Access
Citation
ID:
272946
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
272946
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
